FindMyKOL
Clinical trialNCT00672191CompletedPhase 2Interventional

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

SponsorArgos TherapeuticsEnrollment59HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to examine the ability of AGS-004 to control HIV-1 replication and to determine if HIV-1 immunotherapy made with dendritic cells is safe and well tolerated, to determine if immunotherapy increases the body's immune response to HIV-1; and, to determine if after stopping anti-HIV drugs, immunotherapy can control the HIV-1 virus.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Southern Alberta Clinic

    Calgary, Alberta, Canada

  • Providence Health Care Society / the University of British Columbia / Bc Centre for Excellence in Hiv/aids

    Vancouver, British Columbia, Canada

  • Hamilton Health Sciences - Mcmaster University Medical Centre

    Hamilton, Ontario, Canada

  • the Ottawa Hospital

    Ottawa, Ontario, Canada

  • Maple Leaf Clinic

    Toronto, Ontario, Canada

  • Sunnybrook Health Sciences Center

    Toronto, Ontario, Canada

  • Uhn

    Toronto, Ontario, Canada

  • Chum

    Montreal, Quebec, Canada

  • Clinique Medical Du Quartier Latin

    Montreal, Quebec, Canada

  • Clinique Medicale L'Actuel

    Montreal, Quebec, Canada

  • Montreal Chest Institute

    Montreal, Quebec, Canada

United States
  • Practice Comprehensive Care Practice Div of Onfectious Disease & Hiv Med

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AGS-004
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2008
Primary completion
31 Aug 2010
Completion
30 Nov 2011
Last update posted
29 Jan 2013
Registered enrollment
59
Registry id
NCT00672191
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.